Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia/ischemia in mice

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 212-225

  Shrivastava, K ^a,b   Llovera, G ^a,b   Recasens, M ^a,b   Chertoff, M ^a,b   Gimenez Llort L ^a,b   Gonzalez, B ^a,b   Acarin, L ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

Hypoxia ischemia; Interleukin 1 ; Interleukin 10; Interleukin 13; Interleukin 4; Interleukin 6; Neonatal brain; Phosphorylated signal transducer and activator of transcription factor 3

Indexed keywords

ACTIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LAMIN B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1 RECEPTOR; TRANSCRIPTION FACTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS CALLOSUM; ENZYME SUBSTRATE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIMIT OF QUANTITATION; MOUSE; NEOCORTEX; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; THALAMUS; WESTERN BLOTTING; ASTROCYTE; ASTROCYTOSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONFOCAL MICROSCOPY; HEMISPHERE; MACROPHAGE; MICROGLIA; NEWBORN; PATHOPHYSIOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOTTING, WESTERN; BRAIN; CYTOKINES; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84880199300     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000348432     Document Type: Conference Paper

References (66)

1. Holling EE, Leviton A: Characteristics of cranial ultrasound white-matter echolucencies that predict disability: A review. Dev Med Child Neurol 1999; 41: 136-139.
2. Platt MJ, Cans C, Johnson A, Surman G, Topp M, Torrioli MG, Krageloh-Mann I: Trends in cerebral palsy among infants of very low birthweight (<1,500 g) or born prematurely (<32 weeks) in 16 European centres: A database study. Lancet 2007; 369: 43-50.
3. Robertson CM, Finer NN, Grace MG: School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr 1989; 114: 753-760.
4. Robertson CM, Grace MG: Validation of prediction of kindergarten-age school-readiness scores of nondisabled survivors of moderate neonatal encephalopathy in term infants. Can J Public Health 1992; 83(suppl 2):S51-S57.
5. Woodward LJ, Edgin JO, Thompson D, Inder TE: Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain 2005; 128: 2578-2587.
6. Allin M, Walshe M, Fern A, Nosarti C, Cuddy M, Rifkin L, Murray R, Rushe T, Wyatt J: Cognitive maturation in preterm and term born adolescents. J Neurol Neurosurg Psychiatry 2008; 79: 381-386.
7. Ferriero DM: Neonatal brain injury. N Engl J Med 2004; 351: 1985-1995.
8. Vannucci SJ, Hagberg H: Gypoxia-ischemia in the immature brain. J Exp Biol 2004; 207: 3149-3154.
9. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, Gustafson KE, Leach TM, Green C, Bara R, Petrie Huitema CM, Ehrenkranz RA, Tyson JE, Das A, Hammond J, Peralta-Carcelen M, Evans PW, Heyne RJ, Wilson-Costello DE, Vaucher YE, Bauer CR, Dusick AM, Adams-Chapman I, Goldstein RF, Guillet R, Papile LA, Higgins RD: Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012; 366: 2085-2092.
10. Gonzalez FF, Ferriero DM: Therapeutics for neonatal brain injury. Pharmacol Ther 2008; 120: 43-53.
11. Jenkins DD, Rollins LG, Perkel JK, Wagner CL, Katikaneni LP, Bass WT, Kaufman DA, Horgan MJ, Languani S, Givelichian L, Sankaran K, Yager JY, Martin RH: Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Cereb Blood Flow Metab 2012; 32: 1888-1896.
12. Alvarez-Diaz A, Hilario E, de Cerio FG, Vallsi-Soler A, Alvarez-Diaz FJ: Gypoxic-ischemic injury in the immature brain - Key vascular and cellular players. Neonatology 2007; 92: 227-235.
13. Dammann O, Durum S, Leviton A: Do white cells matter in white matter damage? Trends Neurosci 2001; 24: 320-324.
14. Northington FJ, Chavez-Valdez R, Martin LJ: Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 2011; 69: 743-758.
15. Vexler ZS, Yenari MA: Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci 2009; 31: 378-393.
16. Faustino JV, Wang X, Johnson CE, Klibanov A, Derugin N, Wendland MF, Vexler ZS: Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 2011; 31: 12992-13001.
17. Cuadros MA, Navascues J: The origin and differentiation of microglial cells during development. Prog Neurobiol 1998; 56: 173-189.
18. Vaccarino FM, Fagel DM, Ganat Y, Maragnoli ME, Ment LR, Ohkubo Y, Schwartz ML, Silbereis J, Smith KM: Astroglial cells in development, regeneration, and repair. Neuroscientist 2007; 13: 173-185.
19. Shrivastava K, Chertoff M, Llovera G, Recasens M, Acarin L: Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia. Neurol Res Int 2012; 2012: 781512.
20. Planas AM, Gorina R, Chamorro A: Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem Soc Trans 2006; 34: 1267-1270.
21. Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C, Collett VJ, Hildebrandt L, Seaton G, Choi SL, Sim SE, Bradley C, Lee K, Zhuo M, Kaang BK, Gressens P, Dournaud P, Fitzjohn SM, Bortolotto ZA, Cho K, Collingridge GL: The Jak/STAT pathway is involved in synaptic plasticity. Neuron 2012; 73: 374-390.
22. Cattaneo E, Conti L, De-Fraja C: Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 1999; 22: 365-369.
23. De-Fraja C, Conti L, Magrassi L, Govoni S, Cattaneo E: Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res 1998; 54: 320-330.
24. Lucchese G, Cambi GE, De Rita F, Faggian G, Mazzucco A, Modesti PA, Luciani GB: Cardioplegia and angiotensin II receptor antagonists modulate signal transducers and activators of transcription activation in neonatal rat myocytes. Artif Organs 2011; 35: 1075-1081.
25. Fukushi S, Yamasaki K, Aiba S: Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol 2011; 165: 990-996.
26. Elango C, Devaraj SN: Immunomodulatory effect of hawthorn extract in an experimental stroke model. J Neuroinflammation 2010; 7: 97.
27. Acarin L, González B, Castellano B: STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol 2000; 59: 151-163.
28. Dziennis S, Alkayed NJ: Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 2008; 19: 341-361.
29. Zhang X, Shan P, Alam J, Fu XY, Lee PJ: Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinasedependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 2005; 280: 8714-8721.
30. Rice JE 3rd, Vannucci RC, Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141.
31. Vannucci RC, Vannucci SJ: A model of perinatal hypoxic-ischemic brain damage. Ann NY Acad Sci 1997; 835: 234-249.
32. Hagberg H, Peebles D, Mallard C: Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002; 8: 30-38.
33. Sheldon RA, Sedik C, Ferriero DM: Strainrelated brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res 1998; 810: 114-122.
34. Northington FJ: Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J 2006; 47: 32-38.
35. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, Vannucci SJ: Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 1999; 55: 158-163.
36. Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H, Baccarini M: Raf1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med 2002; 196: 1347-1353.
37. Benveniste EN, Tang LP, Law RM: Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int J Dev Neurosci 1995; 13: 341-349.
38. Van Wagoner NJ, Benveniste EN: Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999; 100: 124-139.
39. Suzuki S, Tanaka K, Nogawa S, Nagata E, Ito D, Dembo T, Fukuuchi Y: Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1999; 19: 1256-1262.
40. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H: Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-5919.
41. Rothwell NJ, Luheshi GN: Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-625.
42. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM: IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28: 178-182.
43. McAdams RM, Juul SE: The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int 2012; 2012: 561494.
44. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW: Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1beta. J Immunol 1993; 150: 2659-2667.
45. Dinarello CA: Proinflammatory cytokines. Chest 2000; 118: 503-508.
46. Shin WH, Lee DY, Park KW, Kim SU, Yang MS, Joe EH, Jin BK: Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 2004; 46: 142-152.
47. Yang MS, Park EJ, Sohn S, Kwon HJ, Shin WH, Pyo HK, Jin B, Choi KS, Jou I, Joe EH: Interleukin-13 and -4 induce death of activated microglia. Glia 2002; 38: 273-280.
48. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12: 2663-2670.
49. Colton CA: Geterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009; 4: 399-418.
50. Xiong X, Barreto GE, Xu L, Ouyang YB, Xie X, Giffard RG: Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 2011; 42: 2026-2032.
51. Sen E, Levison SW: Astrocytes and developmental white matter disorders. Ment Retard Dev Disabil Res Rev 2006; 12: 97-104.
52. Sullivan SM, Bjorkman ST, Miller SM, Colditz PB, Pow DV: Morphological changes in white matter astrocytes in response to hypoxia/ischemia in the neonatal pig. Brain Res 2010; 1319: 164-174.
53. Gautron L, De Smedt-Peyrusse V, Laye S: Characterization of STAT3-expressing cells in the postnatal rat brain. Brain Res 2006; 1098: 26-32.
54. Murata S, Usuda N, Okano A, Kobayashi S, Suzuki T: Occurrence of a transcription factor, signal transducer and activators of transcription 3 (STAT3), in the postsynaptic density of the rat brain. Mol Brain Res 2000; 78: 80-90.
55. Nguyen-Jackson H, Panopoulos AD, Zhang H, Li HS, Watowich SS: STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction. Blood 2010; 115: 3354-3363.
56. Suzuki S, Tanaka K, Nogawa S, Dembo T, Kosakai A, Fukuuchi Y: Phosphorylation of signal transducer and activator of transcription-3 (STAT3) after focal cerebral ischemia in rats. Exp Neurol 2001; 170: 63-71.
57. Satriotomo I, Bowen KK, Vemuganti R: JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 2006; 98: 1353-1368.
58. Justicia C, Gabriel C, Planas AM: Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through JAK1 and STAT3 in astrocytes. Glia 2000; 30: 253-270.
59. Choi JS, Kim SY, Cha JH, Choi YS, Sung KW, Oh ST, Kim ON, Chung JW, Chun MH, Lee SB, Lee MY: Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia. Glia 2003; 41: 237-246.
60. Bain JM, Ziegler A, Yang Z, Levison SW, Sen E: TGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the 'brain marrow' in a rodent model of neonatal encephalopathy. PLoS One 2010; 5:e9567.
61. Fukuda S, Abematsu M, Mori H, Yanagisawa M, Kagawa T, Nakashima K, Yoshimura A, Taga T: Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein-Smad signaling in neural stem cells. Mol Cell Biol 2007; 27: 4931-4937.
62. Bambrick L, Kristian T, Fiskum G: Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res 2004; 29: 601-608.
63. Haber M, Zhou L, Murai KK: Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J Neurosci 2006; 26: 8881-8891.
64. Nedergaard M, Dirnagl U: Role of glial cells in cerebral ischemia. Glia 2005; 50: 281-286.
65. Yi JH, Park SW, Kapadia R, Vemuganti R: Role of transcription factors in mediating postischemic cerebral inflammation and brain damage. Neurochem Int 2007; 50: 1014-1027.
66. Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, Kawase T, Mihara M, Ohsugi Y, Abe K, Okano H: Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: Possible involvement of STAT3 activation in the protection of neurons. J Neurochem 2005; 94: 459-468.